| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -6,421 | -2,604 |
| Purchase of property and equipment | 0 | 0 |
| Net cash used in investing activities | 0 | 0 |
| Gross proceeds from issuance of common stock | 2,622 | - |
| Direct financing costs for issuance of common stock | 115 | - |
| Proceeds from issuance of common stock-Private Placement | - | 2,121 |
| Gross proceeds from warrant inducement | 2,546 | - |
| Direct financing costs from issuance of common stock | - | 64 |
| Direct transaction costs for warrant inducement | 291 | - |
| Net cash provided by financing activities | 4,762 | 2,057 |
| Net decrease in cash and cash equivalents | -1,659 | -547 |
| Cash and cash equivalents at beginning of period | 9,136 | - |
| Cash and cash equivalents at end of period | 7,477 | - |
Autonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc. (AMIX)